-
PROVIDERS
Watch now
Are you getting the full picture? A webinar series on the power of comprehensive intelligent diagnostics
-
LIFE SCIENCES
ENROLL NOW
Tempus’ Patient-Derived Organoid ScreensEvaluate the efficacy of your preclinical compounds using fixed organoid panels designed for diverse therapeutic applications.Space is limited — enroll by June 30, 2025, to secure your spot.
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Content
-
BlogExpanding the boundaries of precision medicine and research with Tempus One
Ryan Fukushima, Chief Operating Officer -
BlogLeveraging Tempus AI and multimodal data to increase probability of technical success in Biopharma
Iker Huerga, SVP of Life Sciences Strategy -
BlogWelcome Arterys: integrating medical imaging insights to drive better outcomes for patients
Ryan Fukushima, Chief Operating Officer -
BlogPrecision medicine made real: enhancing genetic testing with AI algorithms
Martin Stumpe, Chief of AI -
Blog
Unlocking the value of RNA data
Ryan Fukushima, Chief Operating Officer, and Nike Beaubier, MD, Senior Vice President, Life Science Pathology -
BlogMy takeaways: “Advancing equitable cancer care through innovation” at the 2022 ASCO Annual Meeting
James Chen, MD, Senior Vice President, Cancer Informatics -
BlogEnhancing first-line treatment for Colorectal Cancer with Genomic Profiling and Predictive Diagnostics
Dr. Kimberly Blackwell, Tempus Chief Medical Officer -
BlogBuilding the ECG of the future with Artificial Intelligence
Dr. Brandon Fornwalt, SVP, Cardiology; Dr. Joel Dudley, Chief Scientific Officer; and Dr. Noah Zimmerman, VP, Translational Science -
BlogAdvancing Immunotherapy in Oncology
Eric Lefkofsky, Tempus CEO; Lauren Silvis, Senior Vice President of External Affairs at Tempus -
Blog
Reflections on the 2021 SABCS: harnessing the power of data to advance Breast Cancer research
Dr. Kimberly Blackwell, Tempus Chief Medical Officer